OWCP - OWC Pharmaceutical Research Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
50
Operating Expenses
Research Development
992
712
441
142
Selling General and Administrative
2,168
2,852
4,104
1,997
Total Operating Expenses
3,764
4,296
4,554
2,148
Operating Income or Loss
-3,764
-4,296
-4,554
-2,098
Interest Expense
-
3
-
-
Total Other Income/Expenses Net
5,113
-5,136
-
-
Income Before Tax
1,340
-10,258
-4,558
-2,287
Income from Continuing Operations
1,340
-10,258
-4,558
-2,287
Net Income
1,340
-10,258
-4,558
-2,287
Net Income available to common shareholders
-2,289
-12,705
-4,558
-2,287
EBITDA
-
-10,248
-4,545
-2,088